Cargando…
LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
BACKGROUND: Tamoxifen (TAMR) resistance remains a massive obstacle for breast cancer (BC) management. The precise parts of long non-coding RNA ataxin 8 opposite strand (ATXN8OS) in BC TAMR resistance have not been defined. METHODS: The levels of ATXN8OS, vasodilator-stimulated phosphoprotein (VASP),...
Autores principales: | Zhang, Hongkai, Zhang, Jianni, Dong, Lining, Ma, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754175/ https://www.ncbi.nlm.nih.gov/pubmed/33385064 http://dx.doi.org/10.1515/med-2021-0012 |
Ejemplares similares
-
lncRNA ATXN8OS promotes breast cancer by sequestering miR-204
por: Deng, Zhen, et al.
Publicado: (2019) -
LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer
por: Xue, Xingyang, et al.
Publicado: (2015) -
Noncoding repeat expansions for ALS in Japan are associated with the ATXN8OS gene
por: Hirano, Makito, et al.
Publicado: (2018) -
Curcumin attenuates lncRNA H19-induced epithelial-mesenchymal transition in tamoxifen-resistant breast cancer cells
por: Cai, Jiaqin, et al.
Publicado: (2021) -
LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer
por: Shi, Qianfeng, et al.
Publicado: (2020)